Rationale  ||| S:0 E:10 ||| NNP
and  ||| S:10 E:14 ||| CC
design  ||| S:14 E:21 ||| NN
of  ||| S:21 E:24 ||| IN
the  ||| S:24 E:28 ||| DT
dual-energy  ||| S:28 E:40 ||| JJ
computed  ||| S:40 E:49 ||| JJ
tomography  ||| S:49 E:60 ||| NN
for  ||| S:60 E:64 ||| IN
ischemia  ||| S:64 E:73 ||| JJ
determination  ||| S:73 E:87 ||| NN
compared  ||| S:87 E:96 ||| VBN
to  ||| S:96 E:99 ||| TO
gold  ||| S:99 E:104 ||| JJ
standard  ||| S:104 E:113 ||| JJ
non-invasive  ||| S:113 E:126 ||| JJ
and  ||| S:126 E:130 ||| CC
invasive  ||| S:130 E:139 ||| JJ
techniques  ||| S:139 E:150 ||| NNS
( ||| S:150 E:151 ||| -LRB-
DECIDE-Gold ||| S:151 E:162 ||| NNP
) ||| S:162 E:163 ||| -RRB-
:  ||| S:163 E:165 ||| :
A  ||| S:165 E:167 ||| DT
multicenter  ||| S:167 E:179 ||| JJ
international  ||| S:179 E:193 ||| JJ
efficacy  ||| S:193 E:202 ||| JJ
diagnostic  ||| S:202 E:213 ||| JJ
study  ||| S:213 E:219 ||| NN
of  ||| S:219 E:222 ||| IN
rest-stress  ||| S:222 E:234 ||| JJ
dual-energy  ||| S:234 E:246 ||| JJ
computed  ||| S:246 E:255 ||| JJ
tomography  ||| S:255 E:266 ||| JJ
angiography  ||| S:266 E:278 ||| NN
with  ||| S:278 E:283 ||| IN
perfusion  ||| S:283 E:293 ||| JJ
Dual-energy  ||| S:293 E:305 ||| JJ
CT  ||| S:305 E:308 ||| NNP
( ||| S:308 E:309 ||| -LRB-
DECT ||| S:309 E:313 ||| NNP
)  ||| S:313 E:315 ||| -RRB-
has  ||| S:315 E:319 ||| VBZ
potential  ||| S:319 E:329 ||| JJ
to  ||| S:329 E:332 ||| TO
improve  ||| S:332 E:340 ||| VB
myocardial  ||| S:340 E:351 ||| JJ
perfusion  ||| S:351 E:361 ||| NN
for  ||| S:361 E:365 ||| IN
physiologic  ||| S:365 E:377 ||| JJ
assessment  ||| S:377 E:388 ||| NN
of  ||| S:388 E:391 ||| IN
coronary  ||| S:391 E:400 ||| JJ
artery  ||| S:400 E:407 ||| NN
disease  ||| S:407 E:415 ||| NN
( ||| S:415 E:416 ||| -LRB-
CAD ||| S:416 E:419 ||| NNP
) ||| S:419 E:420 ||| -RRB-
.  ||| S:420 E:422 ||| .
Diagnostic  ||| S:422 E:433 ||| JJ
performance  ||| S:433 E:445 ||| NN
of  ||| S:445 E:448 ||| IN
rest-stress  ||| S:448 E:460 ||| NNP
DECT  ||| S:460 E:465 ||| NNP
perfusion  ||| S:465 E:475 ||| NNS
( ||| S:475 E:476 ||| -LRB-
DECTP ||| S:476 E:481 ||| NNP
)  ||| S:481 E:483 ||| -RRB-
is  ||| S:483 E:486 ||| VBZ
unknown ||| S:486 E:493 ||| JJ
.  ||| S:493 E:495 ||| .
DECIDE-Gold  ||| S:495 E:507 ||| NNP
is  ||| S:507 E:510 ||| VBZ
a  ||| S:510 E:512 ||| DT
prospective  ||| S:512 E:524 ||| JJ
multicenter  ||| S:524 E:536 ||| JJ
study  ||| S:536 E:542 ||| NN
to  ||| S:542 E:545 ||| TO
evaluate  ||| S:545 E:554 ||| VB
the  ||| S:554 E:558 ||| DT
accuracy  ||| S:558 E:567 ||| NN
of  ||| S:567 E:570 ||| IN
DECT  ||| S:570 E:575 ||| NNP
to  ||| S:575 E:578 ||| TO
detect  ||| S:578 E:585 ||| VB
hemodynamic  ||| S:585 E:597 ||| NNS
( ||| S:597 E:598 ||| -LRB-
HD ||| S:598 E:600 ||| NNP
)  ||| S:600 E:602 ||| -RRB-
significant  ||| S:602 E:614 ||| JJ
CAD ||| S:614 E:617 ||| NNP
,  ||| S:617 E:619 ||| ,
as  ||| S:619 E:622 ||| RB
compared  ||| S:622 E:631 ||| VBN
to  ||| S:631 E:634 ||| TO
fractional  ||| S:634 E:645 ||| JJ
flow  ||| S:645 E:650 ||| NN
reserve  ||| S:650 E:658 ||| NN
( ||| S:658 E:659 ||| -LRB-
FFR ||| S:659 E:662 ||| NNP
)  ||| S:662 E:664 ||| -RRB-
as  ||| S:664 E:667 ||| IN
a  ||| S:667 E:669 ||| DT
reference  ||| S:669 E:679 ||| NN
standard ||| S:679 E:687 ||| NN
.  ||| S:687 E:689 ||| .
Eligible  ||| S:689 E:698 ||| JJ
participants  ||| S:698 E:711 ||| NNS
are  ||| S:711 E:715 ||| VBP
subjects  ||| S:715 E:724 ||| NNS
with  ||| S:724 E:729 ||| IN
symptoms  ||| S:729 E:738 ||| NNS
of  ||| S:738 E:741 ||| IN
CAD  ||| S:741 E:745 ||| NNP
referred  ||| S:745 E:754 ||| VBD
for  ||| S:754 E:758 ||| IN
invasive  ||| S:758 E:767 ||| FW
coronary  ||| S:767 E:776 ||| FW
angiography  ||| S:776 E:788 ||| FW
( ||| S:788 E:789 ||| -LRB-
ICA ||| S:789 E:792 ||| NNP
) ||| S:792 E:793 ||| -RRB-
.  ||| S:793 E:795 ||| .
Participants  ||| S:795 E:808 ||| NNS
will  ||| S:808 E:813 ||| MD
undergo  ||| S:813 E:821 ||| VB
DECTP ||| S:821 E:826 ||| NNP
,  ||| S:826 E:828 ||| ,
which  ||| S:828 E:834 ||| WDT
will  ||| S:834 E:839 ||| MD
be  ||| S:839 E:842 ||| VB
performed  ||| S:842 E:852 ||| VBN
by  ||| S:852 E:855 ||| IN
pharmacological  ||| S:855 E:871 ||| JJ
stress ||| S:871 E:877 ||| NN
,  ||| S:877 E:879 ||| ,
and  ||| S:879 E:883 ||| CC
participants  ||| S:883 E:896 ||| NNS
will  ||| S:896 E:901 ||| MD
subsequently  ||| S:901 E:914 ||| RB
proceed  ||| S:914 E:922 ||| VB
to  ||| S:922 E:925 ||| TO
ICA  ||| S:925 E:929 ||| NNP
and  ||| S:929 E:933 ||| CC
FFR ||| S:933 E:936 ||| NNP
.  ||| S:936 E:938 ||| .
HD-significant  ||| S:938 E:953 ||| NNP
CAD  ||| S:953 E:957 ||| NNP
will  ||| S:957 E:962 ||| MD
be  ||| S:962 E:965 ||| VB
defined  ||| S:965 E:973 ||| VBN
as  ||| S:973 E:976 ||| IN
FFR ≤ 0.80 ||| S:976 E:986 ||| CD
.  ||| S:986 E:988 ||| .
In  ||| S:988 E:991 ||| IN
those  ||| S:991 E:997 ||| DT
undergoing  ||| S:997 E:1008 ||| FW
myocardial  ||| S:1008 E:1019 ||| FW
stress  ||| S:1019 E:1026 ||| FW
imaging  ||| S:1026 E:1034 ||| FW
( ||| S:1034 E:1035 ||| -LRB-
MPI ||| S:1035 E:1038 ||| NNP
)  ||| S:1038 E:1040 ||| -RRB-
by  ||| S:1040 E:1043 ||| IN
positron  ||| S:1043 E:1052 ||| FW
emission  ||| S:1052 E:1061 ||| FW
tomography  ||| S:1061 E:1072 ||| FW
( ||| S:1072 E:1073 ||| -LRB-
PET ||| S:1073 E:1076 ||| NNP
) ||| S:1076 E:1077 ||| -RRB-
,  ||| S:1077 E:1079 ||| ,
single  ||| S:1079 E:1086 ||| JJ
photon  ||| S:1086 E:1093 ||| FW
emission  ||| S:1093 E:1102 ||| FW
computed  ||| S:1102 E:1111 ||| FW
tomography  ||| S:1111 E:1122 ||| FW
( ||| S:1122 E:1123 ||| -LRB-
SPECT ||| S:1123 E:1128 ||| NNP
)  ||| S:1128 E:1130 ||| -RRB-
or  ||| S:1130 E:1133 ||| CC
cardiac  ||| S:1133 E:1141 ||| JJ
magnetic  ||| S:1141 E:1150 ||| JJ
resonance  ||| S:1150 E:1160 ||| NN
( ||| S:1160 E:1161 ||| -LRB-
CMR ||| S:1161 E:1164 ||| NNP
)  ||| S:1164 E:1166 ||| -RRB-
imaging ||| S:1166 E:1173 ||| NN
,  ||| S:1173 E:1175 ||| ,
ischemia  ||| S:1175 E:1184 ||| NNS
will  ||| S:1184 E:1189 ||| MD
be  ||| S:1189 E:1192 ||| VB
graded  ||| S:1192 E:1199 ||| VBN
by  ||| S:1199 E:1202 ||| IN
%  ||| S:1202 E:1204 ||| NN
ischemic  ||| S:1204 E:1213 ||| NN
myocardium ||| S:1213 E:1223 ||| NN
.  ||| S:1223 E:1225 ||| .
Blinded  ||| S:1225 E:1233 ||| JJ
core  ||| S:1233 E:1238 ||| NN
laboratory  ||| S:1238 E:1249 ||| NN
interpretation  ||| S:1249 E:1264 ||| NN
will  ||| S:1264 E:1269 ||| MD
be  ||| S:1269 E:1272 ||| VB
performed  ||| S:1272 E:1282 ||| VBN
for  ||| S:1282 E:1286 ||| IN
CCTA ||| S:1286 E:1290 ||| NNP
,  ||| S:1290 E:1292 ||| ,
DECTP ||| S:1292 E:1297 ||| NNP
,  ||| S:1297 E:1299 ||| ,
MPI ||| S:1299 E:1302 ||| NNP
,  ||| S:1302 E:1304 ||| ,
ICA ||| S:1304 E:1307 ||| NNP
,  ||| S:1307 E:1309 ||| ,
and  ||| S:1309 E:1313 ||| CC
FFR ||| S:1313 E:1316 ||| NNP
.  ||| S:1316 E:1318 ||| .
Primary  ||| S:1318 E:1326 ||| JJ
endpoint  ||| S:1326 E:1335 ||| NN
is  ||| S:1335 E:1338 ||| VBZ
accuracy  ||| S:1338 E:1347 ||| VBN
of  ||| S:1347 E:1350 ||| IN
DECTP  ||| S:1350 E:1356 ||| NNP
to  ||| S:1356 E:1359 ||| TO
detect  ||| S:1359 E:1366 ||| VB
≥1  ||| S:1366 E:1369 ||| CD
HD-significant  ||| S:1369 E:1384 ||| JJ
stenosis  ||| S:1384 E:1393 ||| NN
at  ||| S:1393 E:1396 ||| IN
the  ||| S:1396 E:1400 ||| DT
subject  ||| S:1400 E:1408 ||| JJ
level  ||| S:1408 E:1414 ||| NN
when  ||| S:1414 E:1419 ||| WRB
compared  ||| S:1419 E:1428 ||| VBN
to  ||| S:1428 E:1431 ||| TO
FFR ||| S:1431 E:1434 ||| NNP
.  ||| S:1434 E:1436 ||| .
Secondary  ||| S:1436 E:1446 ||| JJ
and  ||| S:1446 E:1450 ||| CC
tertiary  ||| S:1450 E:1459 ||| JJ
endpoints  ||| S:1459 E:1469 ||| NNS
are  ||| S:1469 E:1473 ||| VBP
accuracies  ||| S:1473 E:1484 ||| VBN
of  ||| S:1484 E:1487 ||| IN
combinations  ||| S:1487 E:1500 ||| NNS
of  ||| S:1500 E:1503 ||| IN
DECTP  ||| S:1503 E:1509 ||| NNP
at  ||| S:1509 E:1512 ||| IN
the  ||| S:1512 E:1516 ||| DT
subject  ||| S:1516 E:1524 ||| NN
and  ||| S:1524 E:1528 ||| CC
vessel  ||| S:1528 E:1535 ||| NN
levels  ||| S:1535 E:1542 ||| NNS
compared  ||| S:1542 E:1551 ||| VBN
to  ||| S:1551 E:1554 ||| TO
FFR  ||| S:1554 E:1558 ||| NNP
and  ||| S:1558 E:1562 ||| CC
MPI ||| S:1562 E:1565 ||| NNP
.  ||| S:1565 E:1567 ||| .
DECIDE-Gold  ||| S:1567 E:1579 ||| NNP
will  ||| S:1579 E:1584 ||| MD
determine  ||| S:1584 E:1594 ||| VB
the  ||| S:1594 E:1598 ||| DT
performance  ||| S:1598 E:1610 ||| NN
of  ||| S:1610 E:1613 ||| IN
DECTP  ||| S:1613 E:1619 ||| NNP
for  ||| S:1619 E:1623 ||| IN
diagnosing  ||| S:1623 E:1634 ||| JJ
ischemia ||| S:1634 E:1642 ||| NN
.  ||| S:1642 E:1644 ||| .
